Page last updated: 2024-09-04

docetaxel anhydrous and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene

docetaxel anhydrous has been researched along with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)
Trials
(4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)
Recent Studies (post-2010) (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)
12,1103,2166,9201,92811,354

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guan, X; Huang, Y; Jing, X; Lin, W; Liu, S; Quan, L; Sun, T; Wang, Y; Xie, Z1

Other Studies

1 other study(ies) available for docetaxel anhydrous and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene

ArticleYear
Near-infrared emitting fluorescent BODIPY nanovesicles for in vivo molecular imaging and drug delivery.
    ACS applied materials & interfaces, 2014, Sep-24, Volume: 6, Issue:18

    Topics: Animals; Antineoplastic Agents; Boron Compounds; Docetaxel; Drug Carriers; Fluorescent Dyes; Hep G2 Cells; Humans; Mice; Molecular Imaging; Particle Size; Spectroscopy, Near-Infrared; Taxoids; Xenograft Model Antitumor Assays

2014